I wasn't really across this part of the proposition, can anyone tell me if this comes as a surprise?
- Forums
- ASX - By Stock
- IMM
- Ann: Ulcerative Colitis Phase II Study of GSK2831781 Discontinued
IMM
immutep limited
Add to My Watchlist
0.96%
!
26.3¢

Ann: Ulcerative Colitis Phase II Study of GSK2831781 Discontinued, page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
26.3¢ |
Change
0.003(0.96%) |
Mkt cap ! $379.7M |
Open | High | Low | Value | Volume |
26.0¢ | 27.0¢ | 26.0¢ | $690.2K | 2.585M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
27 | 357681 | 26.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
26.5¢ | 267263 | 30 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
27 | 357681 | 0.260 |
14 | 354329 | 0.255 |
16 | 240864 | 0.250 |
10 | 394783 | 0.245 |
17 | 256230 | 0.240 |
Price($) | Vol. | No. |
---|---|---|
0.265 | 267263 | 30 |
0.270 | 410784 | 13 |
0.275 | 364901 | 8 |
0.280 | 53572 | 6 |
0.285 | 43054 | 5 |
Last trade - 13.41pm 18/07/2025 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |